Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGastroenterology Physician in Atlanta, GA
NPI: 1013113364Primary Practice Location
NORTHSIDE HOSPITAL
1000 Johnson Ferry Rd NE, Atlanta, GA
Primary Employer
Aga Professional Services, LLC
atlantagastro.com
HQ Phone
Get M.D. Nitin's Phone NumberMobile
Get M.D. Nitin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMS State Medical License
MA State Medical License
GA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 82 | 82 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 80 | 81 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 76 | 90 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 68 | 94 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 35 | 41 |
Negative results need airing too.
Authors: Gupta, Nitin, Stopfer, Mark
Journal: Nature
Clinical profile of patients seeking services at urban community psychiatric services in Chandigarh.
Authors: Patra, Suravi, Chavan, Bir Singh, Gupta, Nitin, Sidana, Ajeet
Journal: Indian J Psychiatry
Clinical profile and predictors for outcome in children presenting with Guillain-Barré syndrome.
Authors: Sonali Singh, Nitin Gupta, Arpita Gupta, Anurag Chandel, Sneha Waghela, Pallavi Saple
Publication Date: 2020-05-21
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: TAK-018, DRUG: TAK-018 Placebo
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
